FastSense
FastSense Innovations is a healthcare technology company founded in 2018, focused on advancing diagnostics through AI, molecular biology, and smartphone-based devices. Their patented nucleic acid-based test kits detect viral RNA, DNA, and biomolecules with high accuracy. They offer a Sepsis Screening solution using a smartphone app for rapid, cost-effective detection, and develop diagnostic tools for cancers like Hepatocellular Carcinoma and pancreatic cancer, as well as women-centric health issues. Their business model includes product sales and comprehensive services such as diagnostic consultations, training, maintenance, and customized integration. FastSense aims to make diagnostics affordable and accessible globally, leveraging machine learning for predictive modeling and collaborating with healthcare providers and research institutions.
FastSense
FastSense Innovations is a healthcare technology company founded in 2018, focused on advancing diagnostics through AI, molecular biology, and smartphone-based devices. Their patented nucleic acid-based test kits detect viral RNA, DNA, and biomolecules with high accuracy. They offer a Sepsis Screening solution using a smartphone app for rapid, cost-effective detection, and develop diagnostic tools for cancers like Hepatocellular Carcinoma and pancreatic cancer, as well as women-centric health issues. Their business model includes product sales and comprehensive services such as diagnostic consultations, training, maintenance, and customized integration. FastSense aims to make diagnostics affordable and accessible globally, leveraging machine learning for predictive modeling and collaborating with healthcare providers and research institutions.